Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4584  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (209 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article

 Article Access Statistics
    Viewed984    
    Printed10    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
FOREWORD
Year : 2020  |  Volume : 68  |  Issue : 8  |  Page : 161

Foreword


1 Editor, Neuromodulation Supplement, Neurology India
2 Editor, Neurology India

Date of Web Publication5-Dec-2020

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.302479

Rights and Permissions



How to cite this article:
Deogaonkar M, Chandra P. Foreword. Neurol India 2020;68, Suppl S2:161

How to cite this URL:
Deogaonkar M, Chandra P. Foreword. Neurol India [serial online] 2020 [cited 2021 Feb 25];68, Suppl S2:161. Available from: https://www.neurologyindia.com/text.asp?2020/68/8/161/302479




Neuromodulation is one of the fastest-growing branches of medicine in this century. Though neuromodulation has become synonymous with some flagship procedures like deep brain stimulation (DBS), it does not end there. Over the last few years, the scope of neuromodulation has expanded to cover non-nervous system organs. Newer implants and wearables have now made it easy to target distant, peripheral organs. As electrical impulses are the language of the neural networks in the body, it will be apt to say that we are witnessing the growth of ‘Electroceuticals’.

Though DBS has established as a therapy for Parkinson's disease and other movement disorders it is also being increasingly used for psychiatric disorders, pain, epilepsy, memory disorders and addiction. Same is true with spinal cord stimulation (SCS). The initial use of SCS for pain has now expanded to indications like angina, peripheral vascular disease, heart failure. In addition, other modes of neuromodulation like peripheral nerve stimulation (PNS), vagal nerve stimulation (VNS) are increasingly used for neuromodulation. The concept of neuromodulation is now exported out of brain disorders to other systemic disorders like obstructive sleep apnea, bladder and bowel dysfunction.

In India, we are witnessing continued growth of neuromodulation as the number of centres doing it and number of implants are growing every year for the last decade. This supplement tries to cover all the established and growing indications of neuromodulation. The articles in the supplement are tailored to provide the basic information about technique, indications, and outcomes as well as recent advances and updates in this field. It will be useful for beginners in the field as well as established practitioners.

In future, modulation of neural networks will play a major role in controlling and modifying various neurological and non-neurological diseases.








 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow